Riskpilot← Back to searchSign inGet full accessPericardium AB
ABActiveOrg 5567839674Kuttervägen 2Activities of holding companies · NACE 6421Est. 20090 employees
Revenue 2025
SEK 0
EBITDA margin
—
-83% vs 2024
Equity ratio
98.0%
Financial strength
Net profit 2025
SEK 6,7M
+8419% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -146K | -83% |
| Net profit | SEK 6,7M | +8419% |
| Total assets | SEK 7,2M | +0% |
| Equity | SEK 7,1M | +10% |
| Employees | 0 | — |
Legal name
Pericardium AB
Org number
5567839674
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
12 juni 2009
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanterna
Company purpose
Bolagets ska direkt eller genom dotterbolag bedriva medicinsk och bioteknisk forskning och utveckling, äga och förvalta fast och lös egendom samt därmed förenlig verksamhet.
Address
Kuttervägen 2
Email
rickardb@me.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −72 | −58 | −133 | −80 | −146 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −72 | −58 | −133 | −80 | −146 |
| Net financials | −1 | 23 120 | — | — | 6 798 |
| Profit before tax | −74 | 23 061 | −133 | −80 | 6 652 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −74 | 23 061 | −133 | −80 | 6 652 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 7 102 | 23 328 | 6 851 | 7 256 | 7 240 |
| Equity | 7 095 | 23 256 | 6 523 | 6 443 | 7 095 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 7 | 71 | 327 | 813 | 145 |
| Total debt | 7 | 71 | 327 | 813 | 145 |
EBITDA margin
-14641200.0%
This company
15.8%
Market median
-92665923% vs market
20212025
Equity ratio
98.0%
This company
38.2%
Market median
+157% vs market
20212025
Return on equity
93.8%
This company
18.4%
Market median
+410% vs market
20212025
Net profit margin
665188100.0%
This company
8.1%
Market median
+8212198665% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JO Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pericardium AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Olof Palmgren | Chief Auditor | 0 companies |
| Anna Beatrice Brånemark | Deputy Board Member | 0 companies |
| Rickard Sebastian Brånemark | Chairman | 0 companies |
| Anna-Tove Harriet Brånemark | Deputy Board Member | 0 companies |
| Per Rickard Brånemark | Board of Directors | 0 companies |